Evotec's insights into GPCRs and waveRAPID technology reveal new opportunities in drug discovery, focusing on orphan ...

With uncertainty surrounding the future of government funding, the onus is being placed on the private sector to continue ...

Swiss pharma giant Novartis is diving into research on ageing to tap the growing market for drugs that help keep older adults ...

The market will be near about USD 9.1 Billion in 2025 and USD 31.3 Billion in 2035, growing at a CAGR of 13.1% over the estimated period. The introduction of artificial intelligence and machine ...

Laminin 521 (Cat. No. GMP-LA5H24) successfully maintained rapid expansion of human iPSCs, enabling cell passaging after just ...

Dr. D. Wade Clapp's work with British biotech company Healx dates to 2019. Photo by Liz Kaye, Indiana University Indiana ...

Learn about the battle against antimicrobial resistance (AMR) in India, the development of new antibiotics, and the urgent ...

The emergence and global spread of antimicrobial resistance (AMR) pose one of the most critical threats to public health in ...

Technology relies heavily on global supply chains, which makes it particularly susceptible to trade policy disruptions.

You would be off to a great start toward making that million bucks if you bought IonQ at its initial public offering (IPO) in ...

Automated cell biology systems are revolutionizing research efficiency, offering precision, scalability, and reproducibility in cellular analysis and drug discovery workflows.” — Sabyasachi Ghosh, ...

Analysts at MarketsandMarkets expect the AI healthcare sector to grow at a 38.6% CAGR, topping $110 billion by 2030. Accenture goes even further, estimating AI could inject another $461 billion in ...